Show simple item record

dc.contributor.authorMartínez, Paula J
dc.contributor.authorBaldan-Martin, Montserrat
dc.contributor.authorLopez, Juan Antonio 
dc.contributor.authorMartín-Lorenzo, Marta
dc.contributor.authorSantiago-Hernández, Aránzazu
dc.contributor.authorAgudiez, Marta
dc.contributor.authorCabrera, Martha
dc.contributor.authorCalvo, Eva
dc.contributor.authorVazquez, Jesus 
dc.contributor.authorRuiz-Hurtado, Gema
dc.contributor.authorVivanco, Fernando
dc.contributor.authorRuilope, Luis M
dc.contributor.authorBarderas, Maria G
dc.contributor.authorAlvarez-Llamas, Gloria
dc.date.accessioned2019-03-18T11:34:08Z
dc.date.available2019-03-18T11:34:08Z
dc.date.issued2019-03
dc.identifier.citationAtherosclerosis. 2019; 282:67-74es_ES
dc.identifier.issn0021-9150es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/7351
dc.description.abstractBACKGROUND AND AIMS: The predictive value of traditional CV risk calculators is limited. Novel indicators of CVD progression are needed particularly in the young population. The main aim of this study was the identification of a molecular profile with added value to classical CV risk estimation. METHODS: Eighty-one subjects (30-50 years) were classified in 3 groups according to their CV risk: healthy subjects; individuals with CV risk factors; and those who had suffered a previous CV event. The urine proteome was quantitatively analyzed and significantly altered proteins were identified between patients' groups, either related to CV risk or established organ damage. Target-MS and ELISA were used for confirmation in independent patients' cohorts. Systems Biology Analysis (SBA) was carried out to identify functional categories behind CVD. RESULTS: 4309 proteins were identified, 75 of them differentially expressed. ADX, ECP, FETUB, GDF15, GUAD and NOTCH1 compose a fingerprint positively correlating with lifetime risk estimate (LTR QRISK). Best performance ROC curve was obtained when ECP, GDF15 and GUAD were combined (AUC = 0.96). SBA revealed oxidative stress response, dilated cardiomyopathy, signaling by Wnt and proteasome, as main functional processes related to CV risk. CONCLUSIONS: A novel urinary protein signature is shown, which correlates with CV risk estimation in young individuals. Pending further confirmation, this six-protein-panel could help in CV risk assessment.es_ES
dc.description.sponsorshipISCIII co-supported by FEDER grants (PI14/01650, PI14/01917, PI14/01841, PI16/01334, IF08/3667-1, FI12/00126, CPII15/00027, CP15/00129, PT13/0001/0013, PI17/01093, PI17/01193, PRB3 (IPT17/0019 ISCIIIS-GEFI/ERDF, REDinREN (RD12/0021/0001, RD16/0009)), Fundación SENEFRO, Fundación Íñigo Álvarez de Toledo and Fundación Conchita Rábago de Jiménez Díaz. Results are lined up with the Spanish initiative on the Human Proteome Project.es_ES
dc.language.isoenges_ES
dc.type.hasVersionAMes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectBiomarkerses_ES
dc.subjectCardiovascular riskes_ES
dc.subjectEarly preventiones_ES
dc.subjectLifetime riskes_ES
dc.subjectProteomicses_ES
dc.subjectSystems biology analysises_ES
dc.titleIdentification of six cardiovascular risk biomarkers in the young population: A promising tool for early preventiones_ES
dc.typejournal articlees_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.identifier.pubmedID30690299es_ES
dc.format.volume282es_ES
dc.format.page67-74es_ES
dc.identifier.doi10.1016/j.atherosclerosis.2019.01.003es_ES
dc.contributor.funderInstituto de Salud Carlos III 
dc.contributor.funderFundación SENEFRO 
dc.contributor.funderFundación Íñigo Álvarez de Toledo
dc.contributor.funderFundación Conchita Rábago de Jiménez Díaz 
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) 
dc.description.peerreviewedes_ES
dc.identifier.e-issn1879-1484es_ES
dc.relation.publisherversionhttps://doi.org/10.1016/j.atherosclerosis.2019.01.003
dc.identifier.journalAtherosclerosises_ES
dc.repisalud.orgCNICCNIC::Unidades técnicas::Proteómica / Metabolómicaes_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Proteómica cardiovasculares_ES
dc.repisalud.institucionCNICes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI14/01650es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI14/01917es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI14/01841es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI16/01334es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/IF08/3667-1es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/FI12/00126es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/CPII15/00027es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/CP15/00129es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PT13/0001/0013es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI17/01093es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/IPT17/0019es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RD12/0021/0001es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RD16/0009es_ES
dc.rights.accessRightsopen accesses_ES


Files in this item

Acceso Abierto
Thumbnail
Acceso Abierto
Acceso Abierto
Acceso Abierto
Acceso Abierto
Acceso Abierto
Acceso Abierto

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
This item is licensed under a: Attribution-NonCommercial-NoDerivatives 4.0 Internacional